Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001373604-25-000043
Filing Date
2025-03-03
Accepted
2025-03-03 14:03:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4629
  Complete submission text file 0001373604-25-000043.txt   6351
Mailing Address 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077
Business Address 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077 317-344-2447
BML Investment Partners, L.P. (Filed by) CIK: 0001373604 (see all company filings)

EIN.: 383708345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address YALELAAN 62 UTRECHT P7 3584 CM
Business Address YALELAAN 62 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Subject) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92425 | Film No.: 25696559
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)